Bypassing the Need for Cell Permeabilization: Nanobody CDR3 Peptide Improves Binding on Living Bacteria
Bioconjugate Chemistry · 2023
DOI: 10.1021/acs.bioconjchem.3c00116 ↗Kurz gefasst
Fachartikel in der Zeitschrift Bioconjugate Chemistry, 2023. Verfasst von A Breine und 9 weiteren Autor:innen. Beteiligte Einrichtung: Microbial Resistance and Drug Discovery, VIB-VUB Center for Structural Biology, VIB, Flanders Institute for Biotechnology, 1050 Brussels, Belgium. Hauptthemen laut MEDLINE: Peptides, Acinetobacter baumannii. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 77 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Vlaams Instituut voor Biotechnologie, Vrije Universiteit Brussel, Fonds Wetenschappelijk Onderzoek.
Abstract (Originalsprache)
Membrane interaction constitutes to be an essential parameter in the mode of action of entities such as proteins, as well as cell-penetrating and antimicrobial peptides, resulting in noninvasive or lytic activities depending on the membrane compositions and interactions. Recently, a nanobody able to interact with the top priority, multidrug-resistant bacterial pathogen Acinetobacter baumannii was discovered, although binding took place with fixed cells only. To potentially overcome this limitation, linear peptides corresponding to the complementarity-determining regions (CDR) were synthesized and fluorescently labeled. Microscopy data indicated clear membrane interactions of the CDR3 sequence with living A. baumannii cells, indicating both the importance of the CDR3 as part of the parent nanobody paratope and the improved binding ability and thus avoiding the need for permeabilization of the cells. In addition, cyclization of the peptide with an additionally introduced rigidifying 1,2,3-triazole bridge retains its binding ability while proteolytically protecting the peptide. Overall, this study resulted in the discovery of novel peptides binding a multidrug-resistant pathogen.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Microbial Resistance and Drug Discovery, VIB-VUB Center for Structural Biology, VIB, Flanders Institute for Biotechnology, 1050 Brussels, Belgium.
- Structural Biology Brussels, Vrije Universiteit Brussel, Pleinlaan 2, 1050 Brussels, Belgium.
- Research Group of Organic Chemistry, Vrije Universiteit Brussel, Pleinlaan 2, 1050 Brussels, Belgium.
- CNRS, BioCIS, CY Cergy-Paris Université, 95000 Neuville sur Oise, France.
- Structural and Molecular Microbiology, Structural Biology Research Center, VIB, 1050 Brussels, Belgium.
ORCID-Profile: K Van Holsbeeck, M Mannes, J Steyaert, S Ballet, C Van der Henst
Förderung
- Vlaams Instituut voor Biotechnologie
- Vrije Universiteit Brussel
- Fonds Wetenschappelijk Onderzoek
Zitieren
APA
Breine, A., Van Holsbeeck, K., Martin, C., Gonzalez, S., Mannes, M., Pardon, E., Steyaert, J., Remaut, H., Ballet, S., & Van der Henst, C. (2023). Bypassing the Need for Cell Permeabilization: Nanobody CDR3 Peptide Improves Binding on Living Bacteria. Bioconjugate Chemistry. https://doi.org/10.1021/acs.bioconjchem.3c00116
Vancouver
Breine A, Van Holsbeeck K, Martin C, Gonzalez S, Mannes M, Pardon E, et al. Bypassing the Need for Cell Permeabilization: Nanobody CDR3 Peptide Improves Binding on Living Bacteria. Bioconjugate Chemistry. 2023. doi:10.1021/acs.bioconjchem.3c00116
BibTeX
@article{Breine2023,
author = {Breine, A and Van Holsbeeck, K and Martin, C and Gonzalez, S and Mannes, M and Pardon, E and Steyaert, J and Remaut, H and Ballet, S and Van der Henst, C},
title = {Bypassing the Need for Cell Permeabilization: Nanobody CDR3 Peptide Improves Binding on Living Bacteria},
journal = {Bioconjugate Chemistry},
year = {2023},
doi = {10.1021/acs.bioconjchem.3c00116}
}
EUVIMED